Spyre Therapeutics is pricing the public offering at $18.50 per share

Spyre Therapeutics is pricing the public offering at $18.50 per share

international_newspapers_108x81 Spyre Therapeutics is pricing the public offering at $18.50 per share
Spyre Therapeutics is pricing the public offering at $18.50 per share

Share this content:

Post Comment